Azenta, Inc. (AZTA)
After hours:
| Previous Close | 50.95 |
| Open | 51.09 |
| Bid | 50.45 x 200 |
| Ask | 50.56 x 200 |
| Day's Range | 50.01 - 51.48 |
| 52 Week Range | 42.90 - 69.16 |
| Volume | |
| Avg. Volume | 480,133 |
| Market Cap | 2.723B |
| Beta (5Y Monthly) | 1.51 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.72 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Dec 02, 2021 |
| 1y Target Est | 62.60 |
PR NewswireAzenta to Participate in the Jefferies Global Healthcare Conference
Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in the Jefferies Global Healthcare Conference in New York, NY, on Wednesday, June 5, 2024, which includes a presentation beginning at 11:00 am ET. The live webcast can be accessed through the Azenta investor relations website at https://investors.azenta.com/events. A replay of the webcast will be available following the event.
PR NewswireAzenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
Azenta, Inc. (Nasdaq: AZTA) today announced the grand opening of the new Genomics Laboratory in Oxford, UK, expanding its global reach of GENEWIZ Multiomics & Synthesis Solutions further in the UK market. The new laboratory brings Azenta closer to UK-based researchers, providing advanced next-generation sequencing (NGS) platforms and a local team of top-tier scientists from Oxford.
GuruFocus.comAzenta Inc (AZTA) Q2 Fiscal 2024 Earnings: Revenue Growth Amid Challenges
Revenue Surpasses Estimates, EPS Aligns with Projections
